These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20963551)

  • 21. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis.
    Zou Z; Fairley CK; Ong JJ; Hocking J; Canfell K; Ma X; Chow EPF; Xu X; Zhang L; Zhuang G
    Lancet Glob Health; 2020 Oct; 8(10):e1335-e1344. PubMed ID: 32971056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India.
    Diaz M; Kim JJ; Albero G; de Sanjosé S; Clifford G; Bosch FX; Goldie SJ
    Br J Cancer; 2008 Jul; 99(2):230-8. PubMed ID: 18612311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia.
    Setiawan D; Dolk FC; Suwantika AA; Westra TA; WIlschut JC; Postma MJ
    Value Health Reg Issues; 2016 May; 9():84-92. PubMed ID: 27881267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of cervical cancer screening.
    Gustafsson L; Adami HO
    Cancer Causes Control; 1992 Mar; 3(2):125-36. PubMed ID: 1562702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Summary of the screening program for cervical cancer prevention in Poland for the first six months of 2007].
    Spaczyński M; Malkowska-Walczak B
    Ginekol Pol; 2007 Oct; 78(10):821-2. PubMed ID: 18200977
    [No Abstract]   [Full Text] [Related]  

  • 26. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).
    Nelson W; Moser RP; Gaffey A; Waldron W
    J Womens Health (Larchmt); 2009 Nov; 18(11):1759-68. PubMed ID: 19951209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
    Goldhaber-Fiebert JD; Stout NK; Salomon JA; Kuntz KM; Goldie SJ
    J Natl Cancer Inst; 2008 Mar; 100(5):308-20. PubMed ID: 18314477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model.
    Parkin DM; Moss SM
    J Epidemiol Community Health; 1986 Jun; 40(2):143-53. PubMed ID: 3746177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Economic evaluation of fifteen cervical cancer screening strategies in rural China].
    Wang YY; Wang ZJ; Zhang Y; Gao XH; Yang CX; Zhao FH; Qiao YL; Ma L; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2019 Dec; 54(12):840-847. PubMed ID: 31874474
    [No Abstract]   [Full Text] [Related]  

  • 30. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
    Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study.
    Xia C; Xu X; Zhao X; Hu S; Qiao Y; Zhang Y; Hutubessy R; Basu P; Broutet N; Jit M; Zhao F
    BMC Med; 2021 Mar; 19(1):62. PubMed ID: 33653331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Health economic evaluation of bivalent human papilloma virus vaccine in China: based on the dynamic model].
    Song XB; Zhao QJ; Zhou Z; Fang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Sep; 51(9):814-820. PubMed ID: 28881547
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.
    Nahvijou A; Daroudi R; Tahmasebi M; Amouzegar Hashemi F; Rezaei Hemami M; Akbari Sari A; Barati Marenani A; Zendehdel K
    PLoS One; 2016; 11(6):e0156705. PubMed ID: 27276093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deaf Women's Health: Adherence to Breast and Cervical Cancer Screening Recommendations.
    Kushalnagar P; Engelman A; Simons AN
    Am J Prev Med; 2019 Sep; 57(3):346-354. PubMed ID: 31377087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing annual cancer screenings for elderly women.
    Smith MK
    J Gerontol Nurs; 1995 Jul; 21(7):12-7. PubMed ID: 7615912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Women's attitudes to and awareness of smear testing and cervical cancer.
    Yu CK; Rymer J
    Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.